US Assisted Living Facility Neurorehabilitation Market

U.S. Assisted Living Facility & Neurorehabilitation Market: Executive Overview

The U.S. assisted living facility (ALF) and neurorehabilitation market is a USD 136.8 billion care-delivery ecosystem in 2025, expanding at a 5.4% CAGR through 2030. This valuation is derived from our proprietary bottom-up model, which reconciles licensed-bed registries, operator-level revenue disclosures, workforce filings, and more than 300 primary interviews spanning operators, clinicians, payers, and technology vendors.

The defining story of this market is convergence. Assisted living is no longer a purely residential product, and neurorehabilitation is no longer a purely clinical one. Operators are layering physical, occupational, speech, and cognitive therapy into residential settings, while post-acute rehabilitation providers are pushing into lower-acuity residential models to capture length-of-stay economics.

Structural facts anchoring our model:

• Approximately 41,465 assisted living communities operate across the United States, with nearly 1.4 million licensed beds and an average community size of just 33 beds.
• More than 1,000,000 Americans reside in assisted living; the modal resident is aged 85+, female, and non-Hispanic white, and typically requires help with only a few activities of daily living (ADLs).
• 57.3% of communities are chain-affiliated, while 42.7% remain independently owned — a fragmentation that shapes pricing power and technology adoption speed.
• The national median cost of assisted living is approximately USD 6,200 per month / USD 74,000 annually, versus USD 114,975 for a semi-private nursing home bed — a widening price advantage that pulls rehabilitation-eligible residents downstream into ALF settings.

Market Sizing, Segmentation Architecture & Forecast Trajectory

Our forecast architecture segments the market along four orthogonal axes — gender, age cohort, service type, and ownership/facility type — each of which exhibits materially different growth elasticity.

Key modeling observations:

• The women segment leads on both share and velocity, driven by greater life expectancy, higher rates of disability and chronic illness, and structurally lower lifetime income that pushes women toward shared-cost residential care.
• The more than 85 cohort is the single most important demand pool. The population aged 85+ is projected to rise from 6.4 million in 2016 to 14.6 million by 2040, and roughly 70% of people turning 65 today will require long-term services and supports.
• Memory care, mobility recovery, and post-stroke rehabilitation are the fastest-growing sub-services inside the ALF envelope, outpacing baseline personal care by 80–140 basis points annually.
• Chain-affiliated operators capture a disproportionate share of neurorehabilitation revenue because they can amortize therapy infrastructure, licensure, and clinical staffing across multiple sites.

Structural Demand Drivers & Growth Accelerants

Demand is being pulled by three reinforcing forces: demographics, disease prevalence, and care-model redesign.

• Demographic math. By 2030, all baby boomers will be over 65, making roughly one in five Americans of retirement age. The UN estimates one in five Americans will be 65+ by 2050, versus 12% globally in 2015 rising toward 22% by 2050.
• Neurological disease burden. Approximately 10 million people live with Parkinson's disease and 2.5 million with multiple sclerosis worldwide. Between 250,000 and 500,000 people sustain spinal cord injuries annually. Stroke is the 5th leading cause of death in the U.S. and the leading cause of disability.
• Traumatic brain injury survivorship. A rising cohort of TBI survivors requires long-duration residential neurorehabilitation, a need that traditional skilled nursing facilities are poorly configured to serve.
• Personalization expectations. Families increasingly demand individualized care plans combining ADL support with therapeutic intervention, driving premium pricing and higher revenue per resident.
• Technology enablement. Computer-aided and robotic rehabilitation devices materially improve patient response rates, shortening recovery cycles and improving unit economics for early-adopting operators.

Operating Economics, Workforce Constraints & Restraints

Workforce is the binding constraint on this market's growth curve.

• As of June 2026, the assisted living profession employed 512,300 workers, with 455,900 full-time nursing and social work employees — roughly 34% of the 1.35 million-strong long-term care nursing workforce.
• Staffing mix is heavily weighted to aides: 68% aides, 18% LPN/LVN, 14% RN — a skill profile ill-suited to advanced neurorehabilitation delivery without contracted clinical partners.
• Turnover, wage inflation, and agency labor premiums compress operating margins and delay adoption of remote monitoring, robotics, and AI-driven analytics.
• Payment friction remains a structural restraint: assisted living is not federally regulated and cannot claim Medicare reimbursement for room and board. Nearly 7 in 10 residents fund care through personal wealth or family contributions, and only about 17% (1 in 5) rely on Medicaid for daily services.
• Capability ceiling. ALFs do not directly provide certain health services and must coordinate with third-party therapy, pharmacy, hospice, dental, and skilled nursing providers, creating fragmentation risk in care continuity.
• Capital intensity. Specialized neurorehabilitation equipment and clinical build-outs require capital that smaller independent operators frequently cannot access.

Value Chain, Technology & Care Delivery Integration

We map the value chain across seven stages, each with distinct margin and control characteristics:

The most consequential shift is at the technology layer. AI-driven motion sensors, acoustic detectors, and wearables continuously analyze vital signs and activity patterns, alerting staff to falls or disrupted sleep and reducing hospitalization risk. Predictive models flag emerging dehydration, infection, or cardiac irregularity before symptoms escalate. Immersive virtual reality and robotic-assisted therapy are now being deployed inside senior living communities as first-line rehabilitation tools rather than novelty amenities.

Employment of these technologies converts a fixed-cost staffing model into a variable, data-informed one — the single largest margin lever available to operators over the forecast window.

Reimbursement, Policy & Payment-Mix Dynamics

Policy is quietly reshaping the economics of this market.

• Approximately 40 states provide or plan to provide partial Medicaid reimbursement for services delivered in assisted living settings.
• Medicaid long-term services and supports (LTSS) spending has shifted decisively toward home and community-based services (HCBS): 63.8% (USD 145.9 billion) of LTSS spending flowed through HCBS in FY2023, up 12.8% year over year, with 49.2% delivered via 1915(c) waivers.
• Medicaid does not pay room and board costs, which keeps private pay dominant and makes real-estate financing a critical strategic capability.
• Medicare Advantage penetration and value-based care are pulling ALFs into formal care-coordination partnerships, rewarding reduced readmissions, medication adherence, and chronic disease management.
• The sector's economic footprint is substantial: USD 43 billion direct and USD 86 billion total economic activity, generating USD 11.2 billion in combined state, local, and federal tax revenue.

Regional Outlook & Investment Attractiveness

Geographic concentration is highly uneven, and capital allocation should follow the demand map rather than legacy footprints.

Structurally, the U.S. will need roughly two million additional senior housing units by 2040 to meet demand. Communities with stable financial profiles are already gravitating toward continuing-care models that admit residents as young as 50 — a forward-integration strategy that expands the addressable base well beyond the 85+ cohort.

Competitive Landscape & Strategic Outlook

The competitive field splits into three strategic archetypes, each with a distinct right to win:

• Chain-affiliated residential platforms — national scale, standardized protocols, strongest access to reimbursement contracting and capital markets.
• Independent community operators — local trust equity and flexibility, but structurally disadvantaged on technology and clinical depth.
• Specialized neurorehabilitation providers — deep clinical capability in TBI, stroke, and spinal cord injury recovery, increasingly seeking residential integration to extend length of stay.

White-space opportunities we identify for the 2025–2030 window:

1. Neurorehabilitation-dedicated ALF wings — purpose-built units combining residential ADL support with in-house PT/OT/SLP, capturing patients currently stranded between hospital discharge and home.
2. Technology-as-a-service partnerships — shared-risk remote monitoring and AI analytics contracts that transfer capital burden away from independent operators.
3. Workforce pipeline co-investment — apprenticeship and certification programs co-funded by operators and state workforce boards to attack the aide shortage at its source.
4. Value-based neurorehabilitation bundles — outcome-linked contracts with Medicare Advantage plans targeting readmission reduction in the TBI and post-stroke populations.

Our base case holds the market at USD 136.8 billion in 2025 growing to approximately USD 178 billion by 2030, with upside contingent on Medicaid room-and-board liberalization and accelerated Medicare Advantage integration.